Published in J Infect Dis on January 01, 2000
Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health (2002) 1.42
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis (2011) 1.16
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy. Obstet Gynecol Int (2013) 0.89
17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription. Virology (2013) 0.89
Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously? BMJ (2001) 0.89
Gynecologic issues in the HIV-infected woman. Infect Dis Clin North Am (2008) 0.83
Sex differences in HIV-1-mediated immunopathology. Curr Opin HIV AIDS (2016) 0.81
The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection. J Virus Erad (2016) 0.77
Gonadal function and reproductive health in women with human immunodeficiency virus infection. Endocrinol Metab Clin North Am (2014) 0.75
Sex and shedding of human immunodeficiency virus. J Infect Dis (2000) 0.75
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol (1989) 5.73
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med (2001) 5.33
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med (1998) 3.81
Natural history of HIV infection. AIDS (1989) 3.75
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS (1994) 3.67
Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology (2003) 2.80
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Global gene profiling in human endometrium during the window of implantation. Endocrinology (2002) 2.48
High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.47
Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect (2006) 2.45
Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44
Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. JAMA (1987) 2.43
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis (2000) 2.36
Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J Virol (1999) 2.29
Immunobiology of endometriosis. Fertil Steril (2001) 2.29
Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med (1995) 2.26
The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22
Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res (2001) 2.21
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med (2001) 2.13
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol (1998) 1.94
Evaluation of tests for infectious mononucleosis through proficiency testing. Health Lab Sci (1976) 1.88
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS (1999) 1.86
Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens (1991) 1.86
Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol (1988) 1.83
Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol (1989) 1.82
Reduction of variation in results of rheumatoid factor tests by use of a serum reference preparation. J Clin Microbiol (1977) 1.76
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A (2000) 1.72
Prehospital stability of diazepam and lorazepam. Am J Emerg Med (1999) 1.72
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis (1990) 1.67
CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep (1990) 1.66
Center for disease control diagnostic immunology proficiency testing program results for 1976. J Clin Microbiol (1977) 1.64
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab (1996) 1.64
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst (1984) 1.59
The underreporting of deaths of American Indian children in California, 1979 through 1993. Am J Public Health (1997) 1.58
Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol (2009) 1.57
Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab (1994) 1.57
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone. Prenat Diagn (1991) 1.56
Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis (2000) 1.54
Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis (1996) 1.53
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS (1999) 1.50
Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet (1994) 1.48
Reference preparation to standardize results of serological tests for rheumatoid factor. J Clin Microbiol (1978) 1.44
Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest (2000) 1.43
Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology (1997) 1.43
Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab (2003) 1.42
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Arch Pathol Lab Med (1992) 1.42
Separation of the pubic symphysis. An underrecognized peripartum complication. J Reprod Med (1986) 1.39
Arteriovenous fistula: a complication following renal biopsy of suspected bilateral Wilms' tumor. Med Pediatr Oncol (1997) 1.38
Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology (1994) 1.37
Center for Disease Control Diagnostic Immunology Proficiency Testing Program results for 1977. J Clin Microbiol (1978) 1.35
Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology (2000) 1.32
Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J Infect Dis (1987) 1.31
Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience (2010) 1.31
Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). Sex Transm Dis (1999) 1.27
Chance, concurrence, and clustering. Analysis of reviewers' recommendations on 1,000 submissions to the Journal of Clinical Investigation. J Clin Invest (1994) 1.27
Consequences of worksite hypertension screening. Differential changes in psychosocial function. Am J Med (1986) 1.25
Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab (1996) 1.24
Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure. AIDS (1998) 1.21
Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol (1994) 1.18
Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet (1974) 1.18
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients. AIDS (2000) 1.18
Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. Radiology (2000) 1.18
A serial study of new MS lesions and the white matter from which they arise. Neurology (1998) 1.17
The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience (2011) 1.16
Center for Disease Control Diagnostic Immunology Proficiency Testing Program results for 1978. J Clin Microbiol (1979) 1.16
Effects of primary care coordination on public hospital patients. J Gen Intern Med (2000) 1.15
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol (2008) 1.15
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy. Clin Infect Dis (2000) 1.14
Measurement of variation and significance in serologic tests. Ann N Y Acad Sci (1983) 1.13
Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS (2000) 1.13
Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab (1997) 1.12
Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology (1994) 1.10
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler (2008) 1.09
Immune activation markers and AIDS prognosis. AIDS (1991) 1.09
Results of the Center for Disease Control Proficiency Testing Program for the detection of hepatitis B surface antigen. J Clin Microbiol (1976) 1.08
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ (1991) 1.08
Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod (1999) 1.08
Mites in the environment of cases of Norwegian scabies. Br J Dermatol (1975) 1.08
Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc (2001) 1.07
Risk of low birth weight infants among black and white parents. Obstet Gynecol (1998) 1.06
Reporting the results of human immunodeficiency virus testing. JAMA (1990) 1.06
Comparison of kinetic and end-point diffusion methods for quantitating human serum immunoglobulins. J Clin Microbiol (1978) 1.06
Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS (2001) 1.06
Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril (1995) 1.04
Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol (2000) 1.04